The Overview of Food Technology to Process Soy Protein Isolate and Its Application toward Food Industry
Abstract
Soy protein isolate (SPI) is the purest form of protein from soybean with minimum protein content of 90%. Due to its high protein content, SPI is commonly used in food processing for improving the quality of food products, including infant formula. The use of SPI in infant formula is mainly designed for infant who cannot tolerate cow’s milk-based formula. This report reviews the benefit of using SPI in soy-based infant formula rather than soymilk from whole soybean itself. It will also review the technology of soy protein isolation which can result SPI for high quality infant formula, including the reducing of unfavourable ingredients which will ensure the safety of soy protein-based infant formula.Downloads
References
Sacks FM, Lichtenstein A, Horn, L. Van , Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113(7):1034. [Google Scholar]
Comission CCA. Codex General Standard for Soy Protein Products. Roma: Food and Agriculture Organization of the United Nations World Health Organization; 1989. [Google Scholar]
Ma Z. Chapter 2: Soy Protein: Research Advances on The Relationships among The Processing Techniques, Nutritional Quality, Functional Properties, and Application in Various Food Products. In: Casamides J, Gonzalez H, editors. Soy Protein: Production Methods, Functional Properties, and Food Sources. New York: Nova Science Publishers; 2014. [Google Scholar]
Odo T. Soy (Soya) milk. Encyclopedia of Food Sciences and Nutrition; 2003. p. 5403–06.
Sarwar G. The protein digestibility–corrected amino acid score method overestimates quality of proteins containing antinutritional factors and of poorly digestible proteins supplemented with limiting amino acids in rats. J Nutr 1997;127(5):758. [Google Scholar]
Hendricks GM, Guo M. Chapter 9: Component Interactions and Processing Damage during the Manufacture of Infant Formula. In: Guo M, editor. Human Milk Biochemistry and Infant Formula Manufacturing Technology. Cambridge: Woodhead Publishing; 2014. [Google Scholar]
Genauer CH, Hammer HF. Chapter 101: Maldigestion and malabsorption. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 9th edition. Philadelphia: Saunders Elsevier; 2010. [Google Scholar]
Endres JG. Soy Protein Products: Characteristic, Nutritional Aspects, and Utilization. Champaign: AOCS Press; 2001. [Google Scholar]
Bhatia J, Greer F. Use of soy protein-based formulas in infant feeding. Pediatrics 2008;121(5):1062. [Google Scholar]
Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis J, et al. Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. Pediatr Gastroenterol Hepatol Nutr 2006;42(4):352. [Google Scholar]
Fomon JS, Ziegler EE. Isolated soy protein in infant feeding. Boca Raton: CRC Press; 1992. [Google Scholar]
Lonnerdal BO, Jayawickrama L, Lien EL. Effect of reducing the phytate content and of partially hydrolyzing the protein in soy formula on zinc and copper absorption and status in infant rhesus monkeys and rat pups. Am J Clin Nutr 1999;69:490. [Google Scholar]
Alibhai Z, Mondor M, Moresoli C, Ippersiel D, Lamarche F. Production of soy protein concentrates/isolates: traditional and membrane technologies. Desalination 2006;191(1–3):351. [Google Scholar]
Goodnight Jr KC, Hartman Jr GH, Marquardt RF. Aqueous Purified Soy Protein and Beverage. US Patent 3995071; 1976.
Rickert DA, Johnson LA, Murphy PA. Improved fractionation of glycinin and β-conglycinin and partitioning of phytochemicals. J Agric Food Chem 2004;52(6):1726. [Google Scholar]
Setchell KDR, Cole J. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem 2003;51(14):4146. [Google Scholar]
Merritt RJ, Jenks BH. Safety of soy-based infant formulas containing isoflavones: the clinical evidence. The Journal of nutrition 2004;134(5):1220. [Google Scholar]
Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 1998;68:1453. [Google Scholar]
Businco L, Bruno G, Giampietro PG, Furcolo G. No oestrogens hormonal effects in long-term soy formula fed children. J. Allergy Clin. Immunol 1999;103. [Google Scholar]
Strom BL, Schinnar R, Ziegler EE, Barnhart KT, Sammel MD, Macones GA, et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. J. Am. Med. Assoc 2001;286:807. [Google Scholar]
Li R. Soy product off-flavor generating, masking, and flavor creating. Boca Raton: Taylor & Francis; 2006. [Google Scholar]
Li H, Zhu K, Zhou H, Peng W. Effects of high hydrostatic pressure treatment on allergenicity and structural properties of soybean protein isolate for infant formula. Food Chem 2012;132(2):808. [Google Scholar]
Montagne D. Van Dael P, Skanderby M, Hugelshofer W. Chapter 9: Infant formulae—powders and liquids. In: Tamime AY, editor. Dairy powders and concentrated products. Westmorland: Wiley Blackwell; 2009. [Google Scholar]
Guo M, Ahmad S. Chapter 7: Ingredients selection for infant formula. In: Guo M, editor. Human Milk Biochemistry and Infant Formula Manufacturing Technology. Cambridge: Woodhead Publishing; 2014. [Google Scholar]
Jiang YJ, Guo M. Chapter 8: Processing technology for infant formula. In: Guo M, editor. Human milk biochemistry and infant formula manufacturing technology. Cambridge: Woodhead Publishing; 2014. [Google Scholar]
Whitman DB. Genetically modified foods: harmful or helpful ?. CSA Discovery guides. 2000. p 1–13.
Bawa AS, Anilakumar KR. Genetically modified foods: safety, risks and public concerns—a review. Int J Food Sci Tech 2013;50(6):1035. [Google Scholar]
Netherwood T, Martín-Orúe SM, Donnell, A.G. O' , Gockling S, Graham J, Mathers JC, et al. Assessing the survival of transgenic plant DNA in the human gastrointestinal tract. Nat Biotechnol 2004;22(2):204. [Google Scholar]
Sbruzzi FA, Venâncio VDP, Resck MCC, Brigagão MRPL, Azevedo L. Transgenic and conventional Brazilian soybeans don't cause or prevent preneoplastic colon lesions or oxidative stress in a 90-day in vivo study. Rev Nutr 2013;26(4):443. [Google Scholar]
Venâncio VP, Silva JPL, Almeida AA, Brigagão MR, Azevedo L. Conventional (MG-BR46 Conquista) and transgenic (BRS Valiosa RR) soybeans have no mutagenic effects and may protect against induced-DNA damage in vivo. Nutr Cancer 2012;64(5):725. [Google Scholar]
Submitted
World Nutrition Journal is an open acces journal and under the licence of
